Intracranial Aneurysm and Hemorrhagic Stroke in Glucocorticoid-remediable Aldosteronism

Hypertension

Volumn 31, Issue 1, 1998, Pages 445-450

  Litchfield, W Reid ^a   Anderson, Bruce F ^a   Weiss, Ruediger J ^a   Lifton, Richard P ^a   Dluhy, Robert G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ADULT; ARTICLE; BRAIN HEMORRHAGE; FEMALE; HUMAN; HYPERALDOSTERONISM; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; MORTALITY; ONSET AGE; REGISTER; RETROSPECTIVE STUDY; SURVIVAL RATE; CONTROLLED STUDY; DISEASE ASSOCIATION; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIGREE; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; STROKE;

ADULT; AGE OF ONSET; CEREBRAL HEMORRHAGE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERALDOSTERONISM; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0031605731     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.445     Document Type: Article

References (40)

1. Lifton RP, Dluhy RG, Powers M, Gutkin M, Fallo F, Gill JRJ, Feld L, Ganguly A, Laidlaw JC, Murnaghan DJ, Kaufman C, Stokigt JR, Ulick S, Lalouel J. Hereditary hypertension caused by a chimaeric gene duplication and ectopic expression of aldosterone synthase. Nature Genetics. 1992;2:66-74.
2. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel J. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992;355:262-265.
3. Litchfield WR, Dluhy RG. Glucocorticoid-remediable aldosteronism. Curr Opin Endocrinol Diabetes. 1996;3:265-270.
4. Litchfield WR, New MI, Coolidge C, Lifton RP, Dluhy RG. Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab. 1997;82(11):3570-3573.
5. Sacco RL, Wolf PA, Bharucha NE, Meeks SL, Kannel WB, Charette LJ, NcNamara PM, Palmer EP, D'Agostino R. Subarachnoid and intracerebral hemorrhage: Natural history, prognosis, and precursive factors in the Framingham study. Neurology. 1984;34:847-854.
6. Schievink WI. Intracranial Aneurysms. N Engl J Med. 1997;336:28-40.
7. Chapman AB, Rubinstein D, Hughes R, Stears JC, Earnest MP, Johnson AM, Gabow PA, Kaehny WD. Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med. 1992;327:916-920.
8. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med. 1993;329:332-342.
9. Bigelow NH. The association of polycystic kidneys with intracranial aneurysms and other related disorders. Am J Med Sci. 1953;225:485-494.
10. Brown RAP. Polycystic disease of the kidneys and intracranial aneurysms: the etiology and interrelationship of these conditions: review of recent literature and report of seven cases in which both conditions coexisted. Glasgow Med J. 1951;32:333-348.
11. Wakabayashi T, Fujita S, Ohbora Y, Suyama T, Tamaki N, Matsumoto S. Polycystic kidney disease and intracranial aneurysms: early angiographic diagnosis and early operation for the unruptured aneurysm. J Neurosurg. 1983;58:488-491.
12. Norrgard O, Angquist K, Fodstad H, Forsell A, Lindberg M. Intracranial aneurysms and heredity. Neurosurgery. 1987;20:236-239.
13. Lozano AM, Leblanc R. Familial intracranial aneurysms. J Neurosurg. 1987;66:522-528.
14. Tobian L, Lange J, Ulm K, Wold L, Iwai J. Potassium reduced cerebral hemorrhage and death rate in hypertensive rats, even when blood pressure is not lowered. Hypertension. 1985;7:I-110-I-114.
15. Litchfield WR, Coolidge C, Silva P, Lifton RP, Fallo F, Williams GH, Dluhy RG. Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab. 1997;82:1507-1510.
16. Takeda R, Matsubara T, Miyamori I, Hatakeyama H, Morise T. Vascular complications in patients with aldosterone producing adenoma in Japan: a comparative study with essential hypertension. J Endocrinol Invest. 1995;18:370-373.
17. Miyamori I, Matsubara T, Takeda R. Controversies in disorders of adrenal hormones. In: Takeda R, Miyamori I, eds. Idiopathic Hyperaldosteronism. Amsterdam: Elsevier Science; 1988:111.
18. Beevers DG, Brown JJ, Ferriss JB, Fraser R, Lever AF, Robertson JIS, Tree M. Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertiary hyperaldosteronism. Q J Med. 1976;45:401-410.
19. Chapman AB, Johnson A, Gabow PA, Schrier RW. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med. 1990;323:1091-1096.
20. Brilla CG, Matsubara LS, Weber KT. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol. 1993;71:12A-16A.
21. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricle in experimental hypertension. Circ Res. 1990;67:1355-1364.
22. Brilla CG, Matsubara LS, Weber KT. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol. 1993;25:563-575.
23. Hall CE, Hall O. Hypertension and hypersalimentation. Lab Invest. 1965;14:285-294.
24. Bonita R. Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: a population-based case-control study. Stroke. 1986;17:831-835.
25. Knekt P, Reunanen A, Aho K, Heliovaara M, Rissanen A, Aromaa A, Impivaara A. Risk factors for subarachnoid hemorrhage in a longitudinal population study. J Clin Epidemiol. 1991;44:933-939.
26. Longstreth WTJ, Nelson LM, Koepsell TD, van Belle G. Cigarette smoking, alcohol use, and subarachnoid hemorrhage. Stroke. 1992;23:1242-1249.
27. Juvela S, Hillbom M, Numminen H, Koskinen P. Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 1993;24:639-646.
28. McCormick WF, Schmalstieg EJ. The relationship of arterial hypertension to intracranial aneurysms. Arch Neurol. 1977;34:285-287.
29. Wiebers DO, Whisnant JP, O'Fallon WM. The natural history of unruptured intracranial aneurysms. N Engl J Med. 1981;304:698.
30. Botero-Velez M, Curtis JJ, Warnock DG. Brief report: Liddle's syndrome revisited-a disorder of sodium reabsorption in the distal tubule. N Engl J Med. 1994;330:178-181.
31. Rosier A, Leiberman E, Cohen T. High frequency of congenital adrenal hyperplasia (classic 11beta-hydroxylase deficiency) among Jews from Morocco. Am J Med Genet. 1992;42:827-834.
32. Hague WM, Honour JW. Malignant hypertension in congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. Clin Endocrinol (Oxf). 1983;18:505-510.
33. Findling JW, Raff H, Hansson JH, Lifton RP. Liddle's syndrome: prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J Clin Endocrinol Metab. 1997;82:1071-1074.
34. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JRJ, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell. 1994;79:407-414.
35. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic hetereogeneity of Liddle's syndrome. Nat Genet. 1995;11:76-82.
36. Hansson JH, Schild L, Lu Y, Wilson TA, Gautschi I, Shimkets R, Nelson-Williams C, Rossier BC, Lifton RP. A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle's syndrome and identifies a proline-rich segment of the protein critical for regulation of channel activity. Proc Natl Acad Sci U S A. 1995;11:11495-11499.
37. Huston JI, Torres VE, Sullivan PP, Offord KP, Wiebers DO. Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1993;3:1871-1877.
38. Ruggieri PM, Poulos N, Masaryk TJ, Ross JS, Obuchowski NA, Awad IA, Braun WE, Nally J, Lewin JS, Modic MT. Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology. 1994;191:33-39.
39. Wiebers DO, Torres VE. Screening for unruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med. 1992;327:953-955.
40. Butler WE, Barker FGI, Crowell RM. Patients with polycystic kidney disease would benefit from routine magnetic resonance angiographic screening for intracerebral aneurysms: a decision analysis. Neurosurgery. 1996;38:506-516.